STAR SPORTS MED (01609): Selected for Inclusion in the Hang Seng Composite Index Constituents

STAR SPORTS MED (01609) announced that, according to the results of the Hang Seng Index Series review published by Hang Seng Indexes Company Limited on August 21, 2026, the company has been selected by Hang Seng Indexes Company Limited to be included in the constituents of the Hang Seng Composite Index, effective from September 7, 2026. After being included in the Hang Seng Composite Index constituents, the companys shares are expected to meet the inclusion criteria for Stock Connect trading (Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect). The Board of Directors believes that being selected for inclusion in the Hang Seng Composite Index is an important milestone in the companys capital market development since its listing, with the potential to further enhance the companys visibility and investability in the Hong Kong capital market, as well as expand its coverage among potential investors. The company will continue to focus on product innovation in the field of sports medicine, creating clinical value, and developing global operations to continuously improve operational quality and create long-term value for its shareholders and investors.